Paediatric clinical trials and drug development
4 European H2020 organizations list this as part of their work — 4 as their primary capability.
Most active in this area
- AZIENDA SANITARIA UNIVERSITARIA FRIULI CENTRALE
Italian university hospital contributing clinical expertise and patient access to European rare disease and paediatric trial networks.
“Partner in c4c (conect4children), the largest European paediatric trial network, and third party in ALBINO studying neonatal brain injury treatment.”
PrimaryIT6 projects - ISTITUTO GIANNINA GASLINI
Italian paediatric hospital contributing clinical expertise in childhood cancer survivorship, paediatric clinical trials, and digital health record implementation across Europe.
“Central participant in c4c (conect4children), a major collaborative network for European clinical trials for children, and contributed to TAT-CF for cystic fibrosis therapeutics.”
PrimaryIT5 projects - INSTYTUT POMNIK CENTRUM ZDROWIA DZIECKA
Poland's leading children's hospital contributing paediatric clinical trial expertise, rare disease research, and drug development for young patients across European networks.
“Central to three projects (SMART, ID-EPTRI, c4c) all focused on improving how medicines are developed, tested, and approved for children.”
PrimaryPL4 projects - ISTITUTO DI RICOVERO E CURA A CARATTERE SCIENTIFICO BURLO GAROFOLO
Italian scientific hospital specializing in maternal-child health research, paediatric clinical trials, and environmental exposure effects on children.
“Core contributor to c4c, a major European network building infrastructure for clinical trials in children, adolescents, and neonates.”
PrimaryIT3 projects